Protagonist TherapeuticsPTGX 
$40.69-1.86%24h
-1.86%24h
Global rank1597
Market cap$2.35B
Change 7d-2.38%
YTD Performance77.30%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Protagonist Therapeutics (PTGX)
As of December 2024, Protagonist Therapeutics has a market cap of $2.35B. This makes Protagonist Therapeutics the world's 1597th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Protagonist Therapeutics from 2016 to 2024
-
Value:-
Market cap history of Protagonist Therapeutics from 2016 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.61B | 22.11% |
| 2023 | $1.32B | 110.17% |
| 2022 | $629.27M | -68.10% |
| 2021 | $1.97B | 69.64% |
| 2020 | $1.16B | 185.96% |
| 2019 | $406.63M | 4.75% |
| 2018 | $388.17M | -67.64% |
| 2017 | $1.20B | -5.41% |
| 2016 | $1.27B | - |
PTGX Market Cap Today is $2.35B -1.86% - 18 Dec 2024
View largest stocks by market cap 
